252 related articles for article (PubMed ID: 24905565)
1. The emergent role of metabolic phenotyping in dynamic patient stratification.
Lindon JC; Nicholson JK
Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):915-9. PubMed ID: 24905565
[TBL] [Abstract][Full Text] [Related]
2. Methods and techniques for metabolic phenotyping.
Wilson I
Bioanalysis; 2017 Jan; 9(1):1-3. PubMed ID: 27921454
[No Abstract] [Full Text] [Related]
3. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
Emwas AH
Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
[TBL] [Abstract][Full Text] [Related]
4. NMR and MS methods for metabonomics.
Dieterle F; Riefke B; Schlotterbeck G; Ross A; Senn H; Amberg A
Methods Mol Biol; 2011; 691():385-415. PubMed ID: 20972767
[TBL] [Abstract][Full Text] [Related]
5. Tissue Multiplatform-Based Metabolomics/Metabonomics for Enhanced Metabolome Coverage.
Vorkas PA; Abellona U MR; Li JV
Methods Mol Biol; 2018; 1738():239-260. PubMed ID: 29654595
[TBL] [Abstract][Full Text] [Related]
6. Metabonomics in pharmaceutical R&D.
Lindon JC; Holmes E; Nicholson JK
FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics of cancer.
Serkova NJ; Glunde K
Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics.
Lindon JC; Nicholson JK
Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():45-69. PubMed ID: 20636074
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
Antonucci R; Atzori L; Barberini L; Fanos V
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):145-8. PubMed ID: 21089734
[TBL] [Abstract][Full Text] [Related]
10. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
Dumas ME; Kinross J; Nicholson JK
Gastroenterology; 2014 Jan; 146(1):46-62. PubMed ID: 24211299
[TBL] [Abstract][Full Text] [Related]
11. New Methodology for Known Metabolite Identification in Metabonomics/Metabolomics: Topological Metabolite Identification Carbon Efficiency (tMICE).
Sanchon-Lopez B; Everett JR
J Proteome Res; 2016 Sep; 15(9):3405-19. PubMed ID: 27490438
[TBL] [Abstract][Full Text] [Related]
12. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
Everett JR
Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
[TBL] [Abstract][Full Text] [Related]
13. Potential effect of diaper and cotton ball contamination on NMR- and LC/MS-based metabonomics studies of urine from newborn babies.
Goodpaster AM; Ramadas EH; Kennedy MA
Anal Chem; 2011 Feb; 83(3):896-902. PubMed ID: 21210639
[TBL] [Abstract][Full Text] [Related]
14. Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection.
Maher AD; Cysique LA; Brew BJ; Rae CD
J Proteome Res; 2011 Apr; 10(4):1737-45. PubMed ID: 21244037
[TBL] [Abstract][Full Text] [Related]
15. [Recent development of metabonomics and its applications in clinical research].
Li H; Jiang Y; He FC
Yi Chuan; 2008 Apr; 30(4):389-99. PubMed ID: 18424407
[TBL] [Abstract][Full Text] [Related]
16. A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.
Jobard E; Pontoizeau C; Blaise BJ; Bachelot T; Elena-Herrmann B; Trédan O
Cancer Lett; 2014 Feb; 343(1):33-41. PubMed ID: 24041867
[TBL] [Abstract][Full Text] [Related]
17. Following dynamic biological processes through NMR-based metabonomics: a new tool in nanomedicine?
Duarte IF
J Control Release; 2011 Jul; 153(1):34-9. PubMed ID: 21406205
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics: a revolution for novel cancer marker identification.
Bu Q; Huang Y; Yan G; Cen X; Zhao YL
Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
[TBL] [Abstract][Full Text] [Related]
19. Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model.
Baur P; Martin FP; Gruber L; Bosco N; Brahmbhatt V; Collino S; Guy P; Montoliu I; Rozman J; Klingenspor M; Tavazzi I; Thorimbert A; Rezzi S; Kochhar S; Benyacoub J; Kollias G; Haller D
J Proteome Res; 2011 Dec; 10(12):5523-35. PubMed ID: 22029571
[TBL] [Abstract][Full Text] [Related]
20. [Nuclear magnetic resonance based metabolic phenotyping for patient evaluations in operating rooms and intensive care units].
Blaise BJ; Gouel-Chéron A; Floccard B; Monneret G; Plaisant F; Chassard D; Javouhey E; Claris O; Allaouchiche B
Ann Fr Anesth Reanim; 2014 Mar; 33(3):167-75. PubMed ID: 24456616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
